Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
July/August 2008, Vol 1, No 6
Bustling Pipeline for Diabetes and Its Metabolic Consequences
Wayne Kuznar
Read More
Editorial
Contracting for Compliance: Using Adherence as a Patient-Centered Measure of Performance
Scott R. Taylor, RPh, MBA
,
J. B. Jones, PhD, MBA
,
Nirav R. Shah, MD,MPH
Read More
Business
Wayward Prescriptions: Costs of Fraud in Payor Plans
Thomas Kaye, RPh, MBA, FASHP
Stakeholder Perspective
Procedures Needed to Prevent Prescription Fraud
by
Susan Sarnoff, DSW
Read More
Bustling Pipeline for Diabetes and Its Metabolic Consequences
Wayne Kuznar
Read More
Industry Trends
FDA Bolsters Its Generic Approval Process: Health Plans Reap the Benefits
Read More
FDA Approvals
Heparin at the Center of the Storm
Mark Senak, JD
Read More
Clinical
Prescribing Warfarin Appropriately to Meet Patient Safety Goals
Lekshmi Dharmarajan, MD, FACP, FACC
,
T. S. Dharmarajan, MD, FACP, AGSF
Stakeholder Perspective
Benefits of Genetic Testing in Warfarin Therapy
by
Teresa DeLuca, MD, MBA
Read More
Regulatory
Treading Water: The No-Growth Investment in Health Services Research
Emily J. Holubowich, MPP
,
Joseph R. Antos, PhD
Stakeholder Perspective
The Golden Age of Health Services Research
by
Joseph R. Antos, PhD
Read More
Conference Highlights ISPOR
The International Society for Pharmacoeconomics and Outcomes Research: Implications for Decision Makers in Healthcare
Gordon M. Cummins, MS
Read More
Conference Highlights ISPOR
Select Topics from ISPOR, May 2008
Read More
Results 1 - 10 of 10